Tagged with GI

Turkey Turkish Cargo, the global air cargo arm of Turkish Airlines, has the world’s largest direct cargo flight network excluding express carriers which has enabled them to deliver 320 million COVID-19 vaccine doses to more than 55 countries around the world. Turhan Özen, its chief cargo officer, explains their services for…

Denmark Erik Jylling of the Danish Regions, the organisation charged with healthcare management for each of Denmark’s five regions, outlines the advantages and challenges which persist within Danish healthcare and sounds a clarion call for faster adaptation and greater collaboration with private industry.   The innovation power that private enterprises have…

Korea Amid global supply shortages and shipment delays for COVID-19 vaccines, South Korea has launched an ambitious 2.2 trillion won (USD 1.9 billion) investment plan to become one of the world’s five largest COVID-19 vaccine manufacturing hubs by 2025. Here, we provide a rundown of some of the key companies involved…

Turkey Over a decade ago, GE Healthcare selected Turkey as an international operational base for its Eastern and Africa Growth Markets (EAGM) and 84 countries are managed from Turkey today. Nael Dabbagh, general manager for the Middle East, Northeast Africa, Turkey, and Central Asia (MENEAT) region, comments on the global firm’s…

Saudi Arabia Altibbi’s Ayman Sharaiha outlines the evolution of the company to date to become the largest digital health platform in MENA, explains how the COVID-19 pandemic has accelerated telehealth adoption, and calls for increased innovative collaboration between pharmaceutical companies, health insurance companies and digital health companies.   A major global challenge…

Saudi Arabia Frederico Silva outlines the highlights of his two years heading up Gilead Sciences’ relatively young Middle-East affiliate, how Gilead has pivoted to serve evolving healthcare needs during the COVID-19 pandemic, and its commitment to inter-stakeholder collaboration in increasingly important markets such as Saudi Arabia.   The Saudi FDA and other…

Europe The Top Five countries in Europe ranked by amount spent on pharma R&D. While some of the continent’s largest and most developed nations are represented, other smaller countries are punching above their weight. This data is taken from the 2021 edition of the EFPIA’s comprehensive annual data review of the European pharma…

APAC The Asia-Pacific (APAC) region is home to around 1.44 billion people, over 60 percent of the world’s population, and a vast diversity of cultures, infrastructures, and economic development. Managing a life sciences company across multiple countries in this region can be extremely challenging but hugely important on both a human…

Europe Drawing from the 2021 edition of the EFPIA’s comprehensive annual data review of the European pharma industry, we present the Top 5 countries across a variety of pharma metrics: from market size to R&D spend, production, exports, imports, and generics penetration.   Made with Visme Infographic Maker   Made with…

Singapore Ashish Mahajan, Partner in Deloitte’s Life Sciences and Healthcare Consulting Practice in Southeast Asia, outlines some of the key trends playing out in the region, the extent to which the COVID-19 pandemic has sped up the industry’s digitalisation efforts, and how Asian innovation stands to develop in the coming years.…

Saudi Arabia Biologix is a Dubai-based firm that represents international pharma companies by bringing innovative drugs to market in the Middle East / North Africa (MENA) region. Its GM, Zeina Sfeir Lahoud, discusses the company’s presence in over 17 countries, their 25 years of experience in Saudi Arabia, and the dynamics shaping…

Singapore One of the main supporting pillars of Singapore’s pharmaceutical industry is its magnificent manufacturing base. Not only does the city-state rank as one of the few countries on the planet that manages to export more medicaments than it imports, but it also plays host to over 50 pharmaceutical manufacturing facilities,…